ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Emilie Decaup
Matched on OpenAlex author ID A5088965175. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper
Papers 3
- FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer. First author DOI 10.15252/emmm.202012010↗
- Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.clinre.2016.10.010↗
- Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. Co-author DOI 10.18632/oncotarget.9296↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Corinne Bousquet · 3 shared papers, 2016–2020 · strength 0.22
- Paper Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2016.10.010↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Stéphane Pyronnet · 3 shared papers, 2016–2020 · strength 0.22
- Paper Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2016.10.010↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Christine Jean · 3 shared papers, 2016–2020 · strength 0.22
- Paper Focal Adhesion Kinase: A promising therapeutic target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2016.10.010↗
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Yvan Martineau · 2 shared papers, 2016–2020 · strength 0.14
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Rémi Samain · 2 shared papers, 2016–2020 · strength 0.14
- Paper FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreati… DOI 10.15252/emmm.202012010↗
- Paper Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associ… DOI 10.18632/oncotarget.9296↗
- Sonia Zaghdoudi · 1 shared paper, 2020 · strength 0.08
- Cindy Neuzillet · 1 shared paper, 2020 · strength 0.08
- Jerome F. Cros · 1 shared paper, 2020 · strength 0.08
- Richard Tomasini · 1 shared paper, 2020 · strength 0.08
- Oliver M.T. Pearce · 1 shared paper, 2020 · strength 0.08
- Siham Moatassim-Billah · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.